Decreased phorbol myristate acetate-induced release of tumor necrosis factor-alpha and interleukin-1 beta from peripheral blood monocytes of patients chronically infected with hepatitis C virus
- PMID: 8843226
- DOI: 10.1093/infdis/174.4.842
Decreased phorbol myristate acetate-induced release of tumor necrosis factor-alpha and interleukin-1 beta from peripheral blood monocytes of patients chronically infected with hepatitis C virus
Abstract
Hepatitis C virus (HCV) has been detected in peripheral blood mononuclear cells (PBMC) from persons chronically infected with HCV. Reports describe altered monocytic function during HCV infection; however, the immunologic consequences of HCV tropism for human macrophages are not well defined. Thus, the possibility that HCV infection of monocytes may alter patterns of cytokine release was investigated. The in vitro secretion of tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta in response to phorbol myristate acetate-stimulated monocytes and PBMC of subjects chronically infected or not infected with HCV was compared. TNF-alpha and IL-1 beta release were suppressed in cells from infected subjects. Although virus-induced immunosuppression is not a major clinical syndrome of HCV infection, the findings support a hypothesis that HCV can induce selective defects in antigen-presenting cells that may enhance the ability of HCV to persist despite the presence of cytotoxic killer cells and antibody directed against HCV.
Similar articles
-
Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein.Hepatology. 1995 Sep;22(3):921-8. Hepatology. 1995. PMID: 7544757
-
Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.FEMS Microbiol Immunol. 1992 Jan;4(2):73-89. doi: 10.1111/j.1574-6968.1992.tb04973.x. FEMS Microbiol Immunol. 1992. PMID: 1547025
-
Low interleukin-10 production by monocytes of patients with a self-limiting hepatitis C virus infection.J Viral Hepat. 2009 Jul;16(7):485-91. doi: 10.1111/j.1365-2893.2009.01094.x. Epub 2009 Mar 11. J Viral Hepat. 2009. PMID: 19302337
-
Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.Am J Respir Cell Mol Biol. 1996 Mar;14(3):279-87. doi: 10.1165/ajrcmb.14.3.8845179. Am J Respir Cell Mol Biol. 1996. PMID: 8845179
-
Role of macrophages and monocytes in hepatitis C virus infections.World J Gastroenterol. 2014 Mar 21;20(11):2777-84. doi: 10.3748/wjg.v20.i11.2777. World J Gastroenterol. 2014. PMID: 24659871 Free PMC article. Review.
Cited by
-
HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C.World J Gastroenterol. 2002 Jun;8(3):562-6. doi: 10.3748/wjg.v8.i3.562. World J Gastroenterol. 2002. PMID: 12046093 Free PMC article.
-
Infection of primary human monocytes by Epstein-Barr virus.J Virol. 2000 Mar;74(6):2612-9. doi: 10.1128/jvi.74.6.2612-2619.2000. J Virol. 2000. PMID: 10684275 Free PMC article.
-
Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C.BMC Nephrol. 2012 Jul 7;13:56. doi: 10.1186/1471-2369-13-56. BMC Nephrol. 2012. PMID: 22768976 Free PMC article. Clinical Trial.
-
Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway.J Virol. 2003 May;77(9):5493-8. doi: 10.1128/jvi.77.9.5493-5498.2003. J Virol. 2003. PMID: 12692250 Free PMC article.
-
Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3.J Virol. 2000 Jun;74(11):5233-41. doi: 10.1128/jvi.74.11.5233-5241.2000. J Virol. 2000. PMID: 10799599 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical